Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg M Delgoffe

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Cancer Immunology Research|December 13, 2016
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor HypoxiaNicole E Scharping, Ashley V Menk, Ryan D Whetstone, et al.
Cancer Immunology Research|October 3, 2019
Metabolic Consequences of T-cell Costimulation in Anticancer ImmunityAlvaro Teijeira, Saray Garasa, Inaki Etxeberria, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2011
Cutting edge: regulatory T cells do not mediate suppression via programmed cell death pathwaysAndrea L Szymczak-Workman, Greg M Delgoffe, Douglas R Green, et al.
Cancer Immunology Research|April 17, 2019
Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic CellsPatricia M Santos, Ashley V Menk, Jian Shi, et al.
Cell Reports|March 8, 2018
IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 CostimulationShankar Revu, Jing Wu, Matthew Henkel, et al.
Journal for Immunotherapy of Cancer|May 14, 2021
Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neckDan P Zandberg, Ashley V Menk, Maria Velez, et al.
Nature Communications|March 15, 2017
Suppressive IL-17A<sup>+</sup>Foxp3<sup>+</sup> and ex-Th17 IL-17A<sup>neg</sup>Foxp3<sup>+</sup> T<sub>reg</sub> cells are a source of tumour-associated T<sub>reg</sub> cellsStephanie Downs-Canner, Sara Berkey, Greg M Delgoffe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2026
Increasing Intrinsic Protein Disorder Improves CD8+ Immunogenicity for a SARS CoV2 Vaccine Candidate AntigenLi Wan, Bingxian Xie, Masahiro Shuda, et al.
Cancer Cell|July 14, 2021
The role of exhaustion in CAR T cell therapyGreg M Delgoffe, Chenqi Xu, Crystal L Mackall, et al.
JCI Insight|February 6, 2019
Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanomaYana G Najjar, Ashley V Menk, Cindy Sander, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Cancer Immunology Research|December 13, 2016
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor HypoxiaNicole E Scharping, Ashley V Menk, Ryan D Whetstone, et al.
Cancer Immunology Research|October 3, 2019
Metabolic Consequences of T-cell Costimulation in Anticancer ImmunityAlvaro Teijeira, Saray Garasa, Inaki Etxeberria, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2011
Cutting edge: regulatory T cells do not mediate suppression via programmed cell death pathwaysAndrea L Szymczak-Workman, Greg M Delgoffe, Douglas R Green, et al.
Cancer Immunology Research|April 17, 2019
Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic CellsPatricia M Santos, Ashley V Menk, Jian Shi, et al.
Cell Reports|March 8, 2018
IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 CostimulationShankar Revu, Jing Wu, Matthew Henkel, et al.
Journal for Immunotherapy of Cancer|May 14, 2021
Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neckDan P Zandberg, Ashley V Menk, Maria Velez, et al.
Nature Communications|March 15, 2017
Suppressive IL-17A<sup>+</sup>Foxp3<sup>+</sup> and ex-Th17 IL-17A<sup>neg</sup>Foxp3<sup>+</sup> T<sub>reg</sub> cells are a source of tumour-associated T<sub>reg</sub> cellsStephanie Downs-Canner, Sara Berkey, Greg M Delgoffe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2026
Increasing Intrinsic Protein Disorder Improves CD8+ Immunogenicity for a SARS CoV2 Vaccine Candidate AntigenLi Wan, Bingxian Xie, Masahiro Shuda, et al.
Cancer Cell|July 14, 2021
The role of exhaustion in CAR T cell therapyGreg M Delgoffe, Chenqi Xu, Crystal L Mackall, et al.
JCI Insight|February 6, 2019
Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanomaYana G Najjar, Ashley V Menk, Cindy Sander, et al.
Pageof 12